Search Results - "Zoccali, A"

Refine Results
  1. 1

    Personality traits and emotional patterns in irritable bowel syndrome by Muscatello, Maria Rosaria A, Bruno, Antonio, Mento, Carmela, Pandolfo, Gianluca, Zoccali, Rocco A

    Published in World journal of gastroenterology : WJG (28-07-2016)
    “…The review focuses on those personality traits(neuroticism, extraversion, openness to experience, agreeableness, and conscientiousness), constructs(alexithymia…”
    Get full text
    Journal Article
  2. 2

    Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome by Muscatello, Maria Rosaria A, Bruno, Antonio, Scimeca, Giuseppe, Pandolfo, Gianluca, Zoccali, Rocco A

    Published in World journal of gastroenterology : WJG (28-06-2014)
    “…Irritable bowel syndrome(IBS)is regarded as a multifactorial disease in which alterations in the brain-gut axis signaling play a major role.The biopsychosocial…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder by Muscatello, Maria Rosaria Anna, Zoccali, Rocco A., Pandolfo, Gianluca, Mangano, Paolo, Lorusso, Simona, Cedro, Clemente, Battaglia, Fortunato, Spina, Edoardo, Bruno, Antonio

    Published in Frontiers in psychiatry (25-10-2019)
    “…Background: Duloxetine hydrochloride (DUL) is an antidepressant included in the pharmacological class of serotonin–norepinephrine reuptake inhibitors approved…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Prevalence of Internet Addiction in a Sample of Southern Italian High School Students by Bruno, Antonio, Scimeca, Giuseppe, Cava, Lucia, Pandolfo, Gianluca, Zoccali, Rocco A., Muscatello, Maria R.A.

    “…The aim of the present study was to assess the prevalence of Internet Addiction (IA) in a sample of Italian high school students accounting for age, gender,…”
    Get full text
    Journal Article
  7. 7

    Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial by Mico’, Umberto, Bruno, Antonio, Pandolfo, Gianluca, Maria Romeo, Vincenzo, Mallamace, Domenico, D’Arrigo, Concetta, Spina, Edoardo, Zoccali, Rocco A, Muscatello, Maria Rosaria A

    Published in International clinical psychopharmacology (01-11-2011)
    “…Antidepressant drugs have often been used as an augmentation strategy for those patients who have demonstrated a suboptimal response to clozapine. The present…”
    Get full text
    Journal Article
  8. 8

    Focus on Disruptive Mood Dysregulation Disorder: A review of the literature by Bruno, Antonio, Celebre, Laura, Torre, Giovanna, Pandolfo, Gianluca, Mento, Carmela, Cedro, Clemente, Zoccali, Rocco A., Muscatello, Maria Rosaria Anna

    Published in Psychiatry research (01-09-2019)
    “…•Disruptive Mood Dysregulation Disorder (DMDD) is a new diagnosis of the DSM-5.•DMDD is characterized by a persistently negative mood and severe temper…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics: a pilot study by Bruno, Antonio, Pandolfo, Gianluca, Crucitti, Manuela, Maisano, Antonino, Zoccali, Rocco A., Muscatello, Maria Rosaria Anna

    Published in The Journal of nutritional biochemistry (01-02-2017)
    “…Second-generation antipsychotics (SGAs) are notoriously associated with a marked increase in body weight and with a wide range of metabolic adverse effects,…”
    Get full text
    Journal Article
  11. 11

    Efficacy and safety of sertindole in schizophrenia: a clinical review by Zoccali, Rocco A, Bruno, Antonio, Muscatello, Maria Rosaria Anna

    Published in Journal of clinical psychopharmacology (01-06-2015)
    “…Sertindole is an atypical antipsychotic reintroduced into the European market in 2005 after a reevaluation of its risks and benefits, under the agreement that…”
    Get full text
    Journal Article
  12. 12

    Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study by Muscatello, Maria Rosaria A, Bruno, Antonio, Pandolfo, Gianluca, Micò, Umberto, Scimeca, Giuseppe, Di Nardo, Floriana, Santoro, Vincenza, Spina, Edoardo, Zoccali, Rocco A

    Published in Schizophrenia research (01-04-2011)
    “…Abstract The simultaneous prescription of two or more antipsychotic drugs in combination is a common treatment strategy for those patients who have…”
    Get full text
    Journal Article
  13. 13

    Extrasensory Perception Experiences and Childhood Trauma: A Rorschach Investigation by Scimeca, Giuseppe, Bruno, Antonio, Pandolfo, Gianluca, La Ciura, Giulia, Zoccali, Rocco A, Muscatello, Maria R A

    Published in The journal of nervous and mental disease (01-11-2015)
    “…ABSTRACTThis study investigated whether people who report recurrent extrasensory perception (ESP) experiences (telepathy, clairvoyance, and precognition) have…”
    Get full text
    Journal Article
  14. 14

    Association between cortisol levels and pain threshold in systemic sclerosis and major depression by Bagnato, Gianluca, Cordova, Francesca, Sciortino, Davide, Miceli, Giovanni, Bruno, Antonio, Ferrera, Antonino, Sangari, Donatella, Coppolino, Giovanni, Muscatello, Maria R. A., Pandolfo, Gianluca, Zoccali, Rocco A., Roberts, William N.

    Published in Rheumatology international (01-03-2018)
    “…Pain perception and threshold show complex interactions with the inflammatory, psychiatric and neuroendocrine stimuli. This study aims to test whether lower…”
    Get full text
    Journal Article
  15. 15

    Anger, Smoking Behavior, and the Mediator Effects of Gender: An Investigation of Heavy and Moderate Smokers by Muscatello, Maria Rosaria Anna, Scimeca, Giuseppe, Lorusso, Simona, Battaglia, Fortunato, Pandolfo, Gianluca, Zoccali, Rocco A., Bruno, Antonio

    Published in Substance use & misuse (16-04-2017)
    “…Background: The existing literature suggests the presence of a possible relationship between high anger levels and smoking behavior; however, there are no…”
    Get full text
    Journal Article
  16. 16

    Augmentation of clozapine with agomelatine in partial-responder schizophrenia: a 16-week, open-label, uncontrolled pilot study by Bruno, Antonio, Zoccali, Rocco A, Abenavoli, Elisabetta, Pandolfo, Gianluca, Scimeca, Giuseppe, Spina, Edoardo, Muscatello, Maria Rosaria Anna

    Published in Journal of clinical psychopharmacology (01-08-2014)
    “…The present 16-week open-label uncontrolled trial was aimed to explore the efficacy of adjunctive agomelatine on clinical symptoms and cognitive functioning in…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Agomelatine in the Treatment of Fibromyalgia: A 12-Week, Open-Label, Uncontrolled Preliminary Study by BRUNO, Antonio, MICO, Umberto, LORUSSO, Simona, COGLIANDRO, Nadia, PANDOLFO, Gianluca, CAMINITI, Maurizio, ZOCCALI, Rocco A, MUSCATELLO, Maria R. A

    Published in Journal of clinical psychopharmacology (01-08-2013)
    “…Pharmacological therapy for fibromyalgia syndrome (FMS) is actually unsatisfactory; analgetic and nonsteroidal anti-inflammatory drugs are not very effective…”
    Get full text
    Journal Article
  20. 20

    Does Personality Matter? Temperament and Character Dimensions in Panic Subtypes by Bruno, Antonio, Muscatello, Maria Rosaria Anna, Pandolfo, Gianluca, Ciura, Giulia La, Quattrone, Diego, Scimeca, Giuseppe, Mento, Carmela, Zoccali, Rocco A

    Published in Noro-Psikiyatri Arsivi (01-12-2018)
    “…Symptomatic heterogeneity in the clinical presentation of Panic Disorder (PD) has lead to several attempts to identify PD subtypes; however, no studies…”
    Get full text
    Journal Article